A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Cryo Cell International Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 14,564 shares of CCEL stock, worth $75,878. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,564
Holding current value
$75,878
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$6.08 - $8.6 $88,549 - $125,250
14,564 New
14,564 $92,000

Others Institutions Holding CCEL

About CRYO CELL INTERNATIONAL INC


  • Ticker CCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 8,519,250
  • Market Cap $44.4M
  • Description
  • Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative med...
More about CCEL
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.